Molecular imaging is a powerful tool for studying disease progression and potential therapies in animals. Optical coherence tomography (OCT) is an important biomedical imaging modality, filling the niche between ultrasound and microscopy. However, OCT suffers from an inherent lack of molecular contrast (the ability to distinguish a molecule of interest from others). This is because the scattering cross-section, the source of contrast in this technique, does not vary widely between molecular species. Researchers have worked around this problem by using OCT with either endogenous or exogenous sources of contrast in a number of schemes. 1, 2 But these methods require computer modeling to decouple scattering from absorption, and they depend on the elastic properties of the tissue.
An alternative technique relies on specialized opticalabsorption contrast agents that enhance the visibility of the molecule of interest by emitting detectable heat when they absorb infrared light. We and others demonstrated that this photothermal detection of contrast agents can be achieved by incorporating an amplitude-modulated laser into the sample arm of a standard OCT system. [3] [4] [5] [6] [7] This approach has the advantage of allowing for noninvasive in vivo molecular imaging in three dimensions.
In photothermal imaging, strong optical absorption by a target of interest-such as a nanoparticle-results in a change in temperature around the particle (i.e., the photothermal effect). Local photothermal heating causes index-of-refraction changes and thermoelastic expansion in the microenvironment surrounding the absorber, thus altering the local optical path length. Changes in the optical path length due to photothermal heating can be imaged directly via the phase information in an OCT image because of the linear relationship between the two parameters. This method, called photothermal OCT (PTOCT), is advantageous because it allows for sensitive detection of absorbing contrast agents over a scattering tissue background without the use of modeling and with minimal effects from tissue properties. In our work, we demonstrated PTOCT as an imaging tool that is especially sensitive to polyethylene-glycol-coated gold nanorod contrast agents. 7 We used an OCT system with an 860nm center wavelength, 51nm full-width-half-maximum super-luminescent diode for the imaging beam, with a 2048 pixel CCD acquiring lines at 10kHz. We fiber-coupled the photothermal laser into the sample arm to spatially co-locate the photothermal and OCT imaging beams (see Figure 1) . PTOCT data was temporally oversampled and continuously captured while amplitude-modulating the photothermal laser at frequency f p with a mechanical chopper. To isolate the PTOCT signal at each point in depth, we performed a Fourier transform in the temporal dimension on the OCT phase signal, and defined the PTOCT signal as the amplitude of the photothermal oscillations at frequency f p .
We quantitatively compared PTOCT data to the predictions of a numerical model nanorods agreed with the temporal heating dynamics predicted by the model, as illustrated for one on-off cycle of the photothermal laser (see Figure 2 ). Both the model and experimental data demonstrated a linear increase in PTOCT signal strength with increased photothermal laser power, indicating that imaging sensitivity can be improved with increased laser power on the sample. However, a linear increase in the photothermal beam amplitude modulation frequency caused a logarithmic falloff in PTOCT signal strength in both the model and experimental data. The imaging speed of PTOCT is defined by the photothermal laser amplitude modulation frequency as well as the number of temporal oversamples. Therefore, imaging speed with PTOCT must be carefully selected to maximize the PTOCT signal and minimize motion artifacts in the sample. Finally, altering the signal intensity in the OCT image did not affect the amplitude of the PTOCT signal, although weaker reflections increased the noise due to decreased phase stability.
We performed PTOCT imaging in agarose capillary tube phantoms to demonstrate the contrast enhancement capability and spatial specificity of PTOCT. An amount of 400pM (picomolar particle concentration) of gold nanorods in agarose displayed a 15 fold increase in PTOCT signal when compared to a negative agarose control. In contrast, the mean OCT signal was not appreciably different between the gold nanorod sample and negative control. Further, we performed PTOCT imaging in vivo in the ear of a live mouse. We injected gold nanorods suspended in Matrigel (an injectable protein solution that solidifies at body temperature) into one ear, with a Matrigel control injection in the other ear. We extracted morphology, Doppler flow and PTOCT image information from the same data set, with a significant increase in PTOCT signal in the ear containing gold nanorods (see Figure 3) .
We provided the first PTOCT images of a contrast agent in vivo. This represents an important step toward highly sensitive molecular imaging in OCT. PTOCT has potential as a powerful tool for studying in vivo disease models, especially when coupled with other functional capabilities of OCT, including
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tissue morphology, microvascular angiography, and flow dynamics. We are currently advancing this technology to image the kinetics of tumor-drug delivery at high resolution in three dimensions. 
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